Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Congrong Tongbian Oral Liquid is a Traditional Chinese Medicine (TCM) botanical formulation developed by Rongchang Pharmaceutical (Zibo) Co., Ltd. for the treatment of constipation, specifically the 'deficiency-type' constipation characterized in TCM theory. The formulation's primary active ingredient is derived from *Cistanche* (Congrong), a desert plant known for its ability to tonify kidney yang and moisten the intestines to facilitate bowel movements. It is typically administered as a 20 ml oral dose. Clinical studies have utilized it as a standard-of-care comparator for evaluating new TCM treatments for chronic constipation. Users should be monitored for potential hepatotoxicity, as prolonged use has been associated with drug-induced liver injury.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Congrong Tongbian.